Results 161 to 170 of about 54,797 (285)
Fetal Growth Restriction (FGR) - Identification and Management
Sri Lanka Journal of Obstetrics and Gynaecology, 2016 The perinatal morbidity and mortality is an important measuring tool in obstetric health care provision in a country. Of factors that affect the perinatal morbidity and mortality, suboptimal fetal growth is a wellestablished cause for increased perinatal morbidity and mortality (1).
openaire +2 more sources
The Journal of Physiology, EarlyView.Abstract figure legend To investigate the role of glucose availability in fetal left ventricle (LV) development, this study assessed whether maternal late gestation undernutrition (LGUN; 50% of Control diet) induced alterations in the contractility, metabolic, and hormonal profile can be ameliorated in LGUN fetuses receiving glucose infusion (LGUN+G ...
Melanie R. Bertossa +10 more
wiley +1 more source
Computational and Systems Oncology, Volume 6, Issue 1, December 2026.ABSTRACT Resistance to chemotherapy, which is demonstrated in almost every patient with advanced‐stage lung cancer (ALC), underscores an urgent need to unravel the underlying molecular mechanisms and identify novel strategies to overcome drug resistance. In the present study, an attempt was made to identify epigenetic targets and modulators that can be
Okibur Rahman +2 more
wiley +1 more source
Increased hepatic glucose production with lower oxidative metabolism in the growth-restricted fetus
JCI InsightFetal growth restriction (FGR) is accompanied by early activation of hepatic glucose production (HGP), a hallmark of type 2 diabetes (T2D). Here, we used fetal hepatic catheterization to directly measure HGP and substrate flux in a sheep FGR model.
Laura D. Brown +6 more
doaj +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 671-679, March 2026.ABSTRACT Objective(s) Timing of birth is complex in early‐onset fetal growth restriction (FGR) and the literature is limited regarding the exact sequence of changes in antenatal parameters. This study aimed to examine this sequence in a large early‐onset FGR cohort. Design Multicenter, retrospective cohort study.
Mette van de Meent +19 more
wiley +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 708-715, March 2026.ABSTRACT Objective Maternal genotypes may be useful to customise foetal growth assessment, but generalisability across diverse racial and ancestral groups remains uncertain. We assessed the generalisability of a genetic risk score for birth weight (GRSBW), derived from participants of predominantly European ancestry, within a diverse U.S.
Bita Tristani‐Firouzi +13 more
wiley +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 626-637, March 2026.ABSTRACT Objective To determine the feasibility of a trial investigating the optimal timing for the birth of women with a suspected late preterm and term SGA baby using either angiogenic biomarker‐led care or standard care. Design A mixed methods study including a randomised feasibility trial, interviews, questionnaires and economic analysis.
Siân Bullough +16 more
wiley +1 more source
Maternal &Child Nutrition, Volume 22, Issue 1, March 2026.ABSTRACT Poor intrauterine growth has long‐term implications for child growth and nutritional status. Fetal malnutrition (FM) is a type of poor intrauterine growth defined by the presence of soft tissue wasting at birth and is identified using the Clinical Assessment of Nutritional Status Score (CANSCORE) tool, independent of gestational age.
Mackenzie E. Bruzzio +6 more
wiley +1 more source
Three-dimensional power Doppler evaluation of cerebral vascular blood flow: A novel tool in the assessment of fetal growth restriction [PDF]
, 2017 Cahill, Allison G +4 more
core +2 more sources